Cargando…

Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries

BACKGROUND: Chronic hepatitis B (CHB) related morbidity and mortality can be reduced through risk group screening, linkage to care and anti-viral treatment. This study estimates the number of CHB cases among foreign-born (migrants) in the European Union and European Economic Area (EU/EEA) countries...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmad, Amena A., Falla, Abby M., Duffell, Erika, Noori, Teymur, Bechini, Angela, Reintjes, Ralf, Veldhuijzen, Irene K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765695/ https://www.ncbi.nlm.nih.gov/pubmed/29325525 http://dx.doi.org/10.1186/s12879-017-2921-8

Ejemplares similares

Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries
por: Falla, A. M., et al.
Publicado: (2018)

Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups
por: Falla, Abby May, et al.
Publicado: (2018)

Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
por: Sharrock, Katherine C., et al.
Publicado: (2022)

The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review
por: Greenaway, Christina, et al.
Publicado: (2018)

Correction: Monitoring progress towards elimination of hepatitis B and C in the EU/EEA
por: Sharrock, Katherine C., et al.
Publicado: (2023)

Screening for Infectious Diseases among Newly Arrived Migrants in EU/EEA Countries—Varying Practices but Consensus on the Utility of Screening
por: Kärki, Tommi, et al.
Publicado: (2014)

The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review
por: Myran, Daniel T, et al.
Publicado: (2018)

The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review
por: Pottie, Kevin, et al.
Publicado: (2018)

Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020
por: Margineanu, Ioana, et al.
Publicado: (2022)

Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review
por: Mason, Lauren MK, et al.
Publicado: (2019)

Accessibility and Acceptability of Infectious Disease Interventions Among Migrants in the EU/EEA: A CERQual Systematic Review
por: Driedger, Matt, et al.
Publicado: (2018)

Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review
por: Mason, Lauren M. K., et al.
Publicado: (2019)

Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA
por: Deblonde, Jessika, et al.
Publicado: (2015)

Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review
por: Agbata, Eric N., et al.
Publicado: (2018)

Reply: Tuberculosis screening in migrants to the EU/EEA and UK
por: Zenner, Dominik, et al.
Publicado: (2023)

The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review
por: Greenaway, Christina, et al.
Publicado: (2018)

The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review
por: Greenaway, Christina, et al.
Publicado: (2018)

Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey
por: Bechini, Angela, et al.
Publicado: (2015)

Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus
por: Vanhamel, Jef, et al.
Publicado: (2023)

Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review
por: HOFSTRAAT, S. H. I., et al.
Publicado: (2017)

Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action
por: Nakitanda, Aya Olivia, et al.
Publicado: (2020)

Hepatitis B virus infection in EU/EEA and United Kingdom prisons: a descriptive analysis
por: Nakitanda, Aya Olivia, et al.
Publicado: (2021)

Correction to: Hepatitis C virus infection in EU/EEA and United Kingdom prisons: Opportunities and challenges for action
por: Nakitanda, Aya Olivia, et al.
Publicado: (2023)

Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review
por: Bivegete, Sandra, et al.
Publicado: (2023)

HIV diagnoses among people born in Ukraine reported by EU/EEA countries in 2022: impact on regional HIV trends and implications for healthcare planning
por: Reyes-Urueña, Juliana, et al.
Publicado: (2023)

The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries
por: Bechini, A., et al.
Publicado: (2016)

Healthcare-associated hepatitis B and C transmission to patients in the EU/EEA and UK: a systematic review of reported outbreaks between 2006 and 2021
por: Singh, Jasleen, et al.
Publicado: (2022)

Is EU/EEA population protected from polio?
por: Nijsten, DRE, et al.
Publicado: (2015)

Monitoring of HIV testing services in the EU/EEA
por: Tavoschi, Lara, et al.
Publicado: (2016)

Upsurge in echovirus 30 detections in five EU/EEA countries, April to September, 2018
por: Broberg, Eeva K, et al.
Publicado: (2018)

Measles Immunization Policies and Vaccination Coverage in EU/EEA Countries over the Last Decade
por: Montalti, Marco, et al.
Publicado: (2020)

Comparison, by Country, of the Uptake of COVID-19 Vaccination by Health Care Workers in the EU/EEA
por: McGlacken, T, et al.
Publicado: (2023)

A systematic review of barriers and facilitators for hepatitis B and C screening among migrants in the EU/EEA region
por: Moonen, Chrissy P. B., et al.
Publicado: (2023)

Limited access to hepatitis B/C treatment among vulnerable risk populations: an expert survey in six European countries
por: Falla, Abby M., et al.
Publicado: (2017)

Language support for linguistic minority chronic hepatitis B/C patients: an exploratory study of availability and clinicians’ perceptions of language barriers in six European countries
por: Falla, Abby M., et al.
Publicado: (2017)

Immunisation Information Systems – useful tools for monitoring vaccination programmes in EU/EEA countries, 2016
por: Derrough, Tarik, et al.
Publicado: (2017)

Interventions to Improve Vaccination Uptake and Cost Effectiveness of Vaccination Strategies in Newly Arrived Migrants in the EU/EEA: A Systematic Review
por: Hui, Charles, et al.
Publicado: (2018)

Reducing burden from respiratory infections in refugees and immigrants: a systematic review of interventions in OECD, EU, EEA and EU-applicant countries
por: Lambert, Jan-Frederic, et al.
Publicado: (2021)

High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020
por: Danis, Kostas, et al.
Publicado: (2020)

Estimation of the number of exposed people during highly pathogenic avian influenza virus outbreaks in EU/EEA countries, October 2016–September 2018
por: Adlhoch, Cornelia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8qn24mad6ds56h75261aveslhq